Bangalore-based telehealth technology company Neurosynaptic Communications Pvt. Ltd. has just announced strategic investment from e-Zest Solutions Ltd. Neurosynaptic will use the funding for research and development.Incorporated in 2002, Neurosynaptic develops ICT (Information and communications technology) based products and low-cost solutions to tackle healthcare challenges in rural areas. Their flagship platform, ReMeDi™ has been deployed in 1600 operational health centers in several developing countries and reaches 45 million people. It is currently the largest telehealth consulting technology platform in India.
Sameer Sawarkar, CEO of Neurosynaptic, said that e-Zest’s strategic investment will help them accelerate their research and development activities and expand their product line. Neurosynaptic's innovative products have already won several awards, including the Technology Pioneer Award by the World Economic Forum, Switzerland, and Global Indus Technovator Award by IBC, MIT, Boston. It was picked as the fastest growing social enterprise in the health category by the ‘Action For India’ Forum, Delhi.
With this strategic investment, e-Zest’s President, senior software industry entrepreneur Shrikant Shingane will be mentoring Neurosynaptic as part of its Board. “In e-Zest, Neurosynaptic has found a partner that will help the company to grow at an accelerated pace while preserving our commitment to customers, partners and the markets that have been responsible for our success from the start,” Sameer said.
“We are really excited about being a partner in revolutionizing healthcare delivery using innovative technologies & business processes. By leveraging e-Zest’s expertise in Cloud, Mobile, UX & Analytics, our goal is to help ReMeDi™ become world leader in Tele-Health market” said Devendra Deshmukh, Chief Executive Officer, e-Zest.
Speaking about the partnership, Eric Savage, Co-Founder & President, Unitus Capital, said: “We expect the strategic partnership between Neurosynaptic and e-Zest to be transformative for both companies. It would further revolutionize delivery of much needed healthcare services in India.” Unitus Capital was the sole advisor to Neurosynaptic for the transaction.